Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Generating Antibiotic Incentives Now Act of 2010
Client: MEDRAD, INC · Firm: FABIANI & COMPANY
HR 6331 Medicare Bill- Issues pertaining to physician reimbursement for medical imaging procedures
Generating Antibiotic Incentives Now Act of 2010
Client: MEDRAD, INC · Firm: FABIANI & COMPANY
HR 6331 Medicare Bill- Issues pertaining to physician reimbursement for medical imaging procedures
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
EDISON PHARMACEUTICALS via FABIANI & COMPANY
2012 · fourth_quarter · 4@
Discussion with DoD Officials regarding company therapeutic's applicability to TBI and possible trials.
Filing targets: Defense, Dept of (DOD)
ZIOPHARM ONCOLOGY, INC. via FABIANI & COMPANY
2012 · third_quarter · Q3
Source: Senate LDA
| VISION ROBOTICS |
| 9 |
| 2006–2009 |
| NANOTHERAPEUTICS INC | 8 | 2007–2009 |
| ARCA BIOPHARMA, INC. | 7 | 2009–2011 |
| CLINICAL DATA INC | 7 | 2008–2009 |
| MEDICIS PHARMACEUTICAL CORPORATION | 6 | 2007–2008 |
| SPALTUDAQ CORPORATION | 6 | 2008–2009 |
| 3-V BIOSCIENCES, INC. | 5 | 2009 |
| AKESIS PHARMACEUTICALS INC | 5 | 2007–2008 |
| AMERICAN PHARMACISTS ASSN | 5 | 2005–2007 |
| ADVANCED LIQUID LOGIC | 4 | 2006–2007 |
| ARBOR VITA CORP | 4 | 2006–2007 |
| OCERA THERAPEUTICS INC. | 4 | 2008–2009 |
| PRIMERADX | 4 | 2008–2009 |
| TRF COALITION | 4 | 2008–2009 |
| TRIOSYN CORP | 4 | 2005–2006 |
| ACHRONIX SEMICONDUCTOR CORPORATION | 3 | 2010 |
| BIO VIGIL LLC | 3 | 2006–2007 |
| LUNDBECK RESEARCH USA, INC. | 3 | 2009 |
| OTONOMY CORPORATION | 3 | 2009 |
| PURDUE PHARMA | 3 | 2005–2006 |
| RIB-X PHARMACEUTICALS | 3 | 2005–2006 |
| ResMed Corp. | 3 | 2005–2006 |
| SARCOMA FOUNDATION OF AMERICA | 3 | 2011 |
| THE MEDICINES COMPANY | 3 | 2009 |
| ACAMBIS INC | 2 | 2005–2006 |
| INNOTECH USA INC | 2 | 2007 |
| TETRAPHASE PHARMACEUTICALS | 2 | 2009 |
| BAXTER HEALTHCARE | 1 | 2003 |
| EDISON PHARMACEUTICALS | 1 | 2012 |
| PATHEON PHARMACEUTICALS SERVICES INC. | 1 | 2012 |
| SAP AMERICA | 1 | 2004 |
| ZIOPHARM ONCOLOGY, INC. | 1 | 2012 |
Generating Antibiotic Incentives Now Act of 2010
Client: MEDRAD, INC · Firm: FABIANI & COMPANY
HR 6331 Medicare Bill- Issues pertaining to physician reimbursement for medical imaging procedures
Generating Antibiotic Incentives Now Act of 2010
Client: MEDRAD, INC · Firm: FABIANI & COMPANY
HR 6331 Medicare Bill- Issues pertaining to physician reimbursement for medical imaging procedures
S.515. Patent Reform Act Provisions relating to apportionment of damages
S.515. Patent Reform Act Provisions relating to apportionment of damages
S 515 Patent Reform Act, provisions relating to apportionment of damages
S.515 Patent Reform Act Provisions relating to the apportionment of damages
S.515 Patent Reform Act Provisions relating to the apportionment of damages
Genomics and Personalized Medicine Act of 2007
Client: CLINICAL DATA INC · Firm: FABIANI & COMPANY
S.976 Genomics and Personalized Medicine Act of 2007, Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations
Genomics and Personalized Medicine Act of 2007
Client: CLINICAL DATA INC · Firm: FABIANI & COMPANY
S.976 Genomics and Personalized Medicine Act of 2007, Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations
Genomics and Personalized Medicine Act of 2007
Client: CLINICAL DATA INC · Firm: FABIANI & COMPANY
S.976 Genomics and Personalized Medicine Act of 2007, Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations
Genomics and Personalized Medicine Act of 2007
Client: CLINICAL DATA INC · Firm: FABIANI & COMPANY
S.976 Genomics and Personalized Medicine Act of 2007, Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations
Medicare Improvements for Patients and Providers Act of 2008
Client: MEDRAD, INC · Firm: FABIANI & COMPANY
HR 6331 Medicare Bill- Issues pertaining to physician reimbursement for medical imaging procedures
Medicare Improvements for Patients and Providers Act of 2008
Client: MEDRAD, INC · Firm: FABIANI & COMPANY
HR 6331 Medicare Bill- Issues pertaining to physician reimbursement for medical imaging procedures
Medicare Improvements for Patients and Providers Act of 2008
Client: MEDRAD, INC · Firm: FABIANI & COMPANY
HR 6331 Medicare Bill- Issues pertaining to physician reimbursement for medical imaging procedures
S.1145 Patent Reform Act Provisions relating to the apportionment of damages
S.1145 Patent Reform Act Provisions relating to the apportionment of damages
S.1145. Patent Reform Act Provisions relating to apportionment of damages
S.1145. Patent Reform Act Provisions relating to apportionment of damages
S.1145 Patent Reform Act Provisions relating to the apportionment of damages
S.1145. Patent Reform Act Provisions relating to apportionment of damages
S.1145. Patent Reform Act Provisions relating to apportionment of damages
S.1145 Patent Reform Act Provisions relating to the apportionment of damages
Genomics and Personalized Medicine Act of 2007
Client: CLINICAL DATA INC · Firm: FABIANI & COMPANY
S.976 Genomics and Personalized Medicine Act of 2007, Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations
Genomics and Personalized Medicine Act of 2007
Client: CLINICAL DATA INC · Firm: FABIANI & COMPANY
S.976 Genomics and Personalized Medicine Act of 2007, Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations
Genomics and Personalized Medicine Act of 2007
Client: CLINICAL DATA INC · Firm: FABIANI & COMPANY
S.976 Genomics and Personalized Medicine Act of 2007, Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations
Genomics and Personalized Medicine Act of 2007
Client: CLINICAL DATA INC · Firm: FABIANI & COMPANY
S.976 Genomics and Personalized Medicine Act of 2007, Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations
Genomics and Personalized Medicine Act of 2007
Client: CLINICAL DATA INC · Firm: FABIANI & COMPANY
S.976 Genomics and Personalized Medicine Act of 2007, Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations
Genomics and Personalized Medicine Act of 2007
Client: CLINICAL DATA INC · Firm: FABIANI & COMPANY
S.976 Genomics and Personalized Medicine Act of 2007, Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations
Genomics and Personalized Medicine Act of 2007
Client: CLINICAL DATA INC · Firm: FABIANI & COMPANY
S.976 Genomics and Personalized Medicine Act of 2007, Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations
Genomics and Personalized Medicine Act of 2007
Client: CLINICAL DATA INC · Firm: FABIANI & COMPANY
S.976 Genomics and Personalized Medicine Act of 2007, Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations
Genomics and Personalized Medicine Act of 2007
Client: CLINICAL DATA INC · Firm: FABIANI & COMPANY
S.976 Genomics and Personalized Medicine Act of 2007, Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations
Genomics and Personalized Medicine Act of 2007
Client: CLINICAL DATA INC · Firm: FABIANI & COMPANY
S.976 Genomics and Personalized Medicine Act of 2007, Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations
Educated members of the House of Representatives on the importance of encouraging innovation in rare cancer drug development.
Filing targets: SENATE
PATHEON PHARMACEUTICALS SERVICES INC. via FABIANI & COMPANY
2012 · first_quarter · 1T
Educating Congressional representatives on issues surrounding the Generic User Fee legislation (GDUFA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SARCOMA FOUNDATION OF AMERICA via FABIANI & COMPANY
2011 · third_quarter · Q3
Educating Congressional Members and staff on the need to encourage FDA to be less conservative in regulating rare cancer drugs and to support accelerated rare cancer therapeuticss approval.
Educating Congressional Members and staff on the need to encourage FDA to be less conservative in regulating rare cancer drugs and to support accelerated rare cancer therapeuticss approval.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SARCOMA FOUNDATION OF AMERICA via FABIANI & COMPANY
2011 · second_quarter · Q2
Educating Congressional Members and staff on the need to encourage FDA to be less conservative in regulating rare cancer drugs and to support accelerated rare cancer therapeuticss approval.
Educating Congressional Members and staff on the need to encourage FDA to be less conservative in regulating rare cancer drugs and to support accelerated rare cancer therapeuticss approval.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SARCOMA FOUNDATION OF AMERICA via FABIANI & COMPANY
2011 · second_quarter · RR
Educating Congressional Members and staff on the need to encourage FDA to be less conservative in regulating rare cancer drugs.
Educating Congressional Members and staff on the need to encourage FDA to be less conservative in regulating rare cancer drugs.
ARCA BIOPHARMA, INC. via FABIANI & COMPANY
2011 · first_quarter · Q1
Federal funding to support development of biopharmaceutical products to treat military and civilian populations
Federal funding to support development of biopharmaceutical products to treat military and civilian populations
Federal funding to support development of biopharmaceutical products to treat military and civilian populations
Filing targets: Defense Threat Reduction Agency (DTRA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ACHRONIX SEMICONDUCTOR CORPORATION via FABIANI & COMPANY
2010 · fourth_quarter · Q4
Defense Policy, production of field programmable gate arrays
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Security Agency (NSA), SENATE
ARCA BIOPHARMA, INC. via FABIANI & COMPANY
2010 · fourth_quarter · Q4
Federal funding to support development of biopharmaceutical products to treat military and civilian populations
Federal funding to support development of biopharmaceutical products to treat military and civilian populations
Federal funding to support development of biopharmaceutical products to treat military and civilian populations
Filing targets: Defense Threat Reduction Agency (DTRA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ARCA BIOPHARMA, INC. via FABIANI & COMPANY
2010 · third_quarter · Q3
Federal funding to support development of biopharmaceutical products to treat military and civilian populations
Federal funding to support development of biopharmaceutical products to treat military and civilian populations
Federal funding to support development of biopharmaceutical products to treat military and civilian populations
Filing targets: Defense Threat Reduction Agency (DTRA), HOUSE OF REPRESENTATIVES, SENATE
BRAINCELLS INC via FABIANI & COMPANY
2010 · second_quarter · 2@
Defense Appropriations RDT&E
Defense Appropriations RDT&E
Defense Appropriations RDT&E
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
ACHRONIX SEMICONDUCTOR CORPORATION via FABIANI & COMPANY
2010 · third_quarter · Q3
Defense Policy, production of field programmable gate arrays
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Security Agency (NSA), SENATE
BRAINCELLS INC via FABIANI & COMPANY
2010 · second_quarter · Q2
Defense Appropriations RDT&E
Defense Appropriations RDT&E
Defense Appropriations RDT&E
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
ARCA BIOPHARMA, INC. via FABIANI & COMPANY
2010 · second_quarter · Q2
Federal funding to support development of biopharmaceutical products to treat military and civilian populations
Federal funding to support development of biopharmaceutical products to treat military and civilian populations
Federal funding to support development of biopharmaceutical products to treat military and civilian populations
Filing targets: Defense Threat Reduction Agency (DTRA), HOUSE OF REPRESENTATIVES, SENATE
ACHRONIX SEMICONDUCTOR CORPORATION via FABIANI & COMPANY
2010 · second_quarter · Q2
Defense Policy, production of field programmable gate arrays
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
BRAINCELLS INC via FABIANI & COMPANY
2010 · first_quarter · Q1
Defense Appropriations RDT&E
Defense Appropriations RDT&E
Defense Appropriations RDT&E
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
ARCA BIOPHARMA, INC. via FABIANI & COMPANY
2010 · first_quarter · Q1
Federal funding to support development of biopharmaceutical products to treat military and civilian populations
Federal funding to support development of biopharmaceutical products to treat military and civilian populations
Federal funding to support development of biopharmaceutical products to treat military and civilian populations
Filing targets: Defense Threat Reduction Agency (DTRA), HOUSE OF REPRESENTATIVES, SENATE
BRAINCELLS INC via FABIANI & COMPANY
2009 · fourth_quarter · Q4
Defense Appropriations RDT&E
Defense Appropriations RDT&E
Defense Appropriations RDT&E
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
ARCA BIOPHARMA, INC. via FABIANI & COMPANY
2009 · fourth_quarter · Q4
Federal funding to support development of biopharmaceutical products to treat military and civilian populations
Federal funding to support development of biopharmaceutical products to treat military and civilian populations
Federal funding to support development of biopharmaceutical products to treat military and civilian populations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PLANET BIOTECHNOLOGY INC via FABIANI & COMPANY
2009 · fourth_quarter · 4T
Department of Defense Appropriations Act of 2010, provisions relating to Department of Defense medical research (RDT&E)
Department of Defense Appropriations Act of 2010, provisions relating to Department of Defense medical research (RDT&E)
Department of Defense Appropriations Act of 2010, funding for biodefense product research
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ARCA BIOPHARMA, INC. via FABIANI & COMPANY
2009 · fourth_quarter · RR
Federal funding to support development of biopharmaceutical products to treat military and civilian populations
Federal funding to support development of biopharmaceutical products to treat military and civilian populations
Federal funding to support development of biopharmaceutical products to treat military and civilian populations
THE MEDICINES COMPANY via FABIANI & COMPANY
2009 · second_quarter · RA
Patent extension/restoration
BRAINCELLS INC via FABIANI & COMPANY
2009 · third_quarter · 3A
Defense Appropriations RDT&E
Defense Appropriations RDT&E
Defense Appropriations RDT&E
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institute of Mental Health (NIMH), Natl Institutes of Health (NIH), SENATE
BRAINCELLS INC via FABIANI & COMPANY
2009 · third_quarter · 3A
Defense Appropriations RDT&E
Defense Appropriations RDT&E
Defense Appropriations RDT&E
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institute of Mental Health (NIMH), Natl Institutes of Health (NIH), SENATE
BRAINCELLS INC via FABIANI & COMPANY
2009 · third_quarter · Q3
Defense Appropriations RDT&E
Defense Appropriations RDT&E
Defense Appropriations RDT&E
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institute of Mental Health (NIMH), Natl Institutes of Health (NIH), SENATE
MEDRAD, INC via FABIANI & COMPANY
2009 · second_quarter · 2A
Addressing trade barriers for medical devices in Australia
Department of Energy and Water and Related Agencies Appropriations Act of 2010, for medical imaging research
Health Reform Legislation, Issues pertaining to physician reimbursement for medical imaging procedures
THE MEDICINES COMPANY via FABIANI & COMPANY
2009 · second_quarter · RA
Patent extension/restoration
THE MEDICINES COMPANY via FABIANI & COMPANY
2009 · third_quarter · RR
Patent extension/restoration
PLANET BIOTECHNOLOGY INC via FABIANI & COMPANY
2009 · first_quarter · Q1
Department of Defense Appropriations Act of 2010, provisions relating to Department of Defense medical research (RDT&E)
Department of Defense Appropriations Act of 2010, funding for biodefense product research
Department of Defense Appropriations Act of 2010, provisions relating to Department of Defense medical research (RDT&E)
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PLANET BIOTECHNOLOGY INC via FABIANI & COMPANY
2009 · second_quarter · Q2
Department of Defense Appropriations Act of 2010, funding for biodefense product research
Department of Defense Appropriations Act of 2010, provisions relating to Department of Defense medical research (RDT&E)
Department of Defense Appropriations Act of 2010, provisions relating to Department of Defense medical research (RDT&E)
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
LUNDBECK RESEARCH USA, INC. via FABIANI & COMPANY
2009 · second_quarter · 2T
Health Reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
3-V BIOSCIENCES, INC. via FABIANI & COMPANY
2009 · second_quarter · Q2
Pursuing government funding to support therapeutic platform development for infectious diseases
Pursuing government funding to support therapeutic platform development for infectious diseases
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
MEDRAD, INC via FABIANI & COMPANY
2009 · second_quarter · Q2
Addressing trade barriers for medical devices in Australia
Patent Reform Act, provisions relating to apportionment of damages
HR 6331 Medicare Bill- Issues pertaining to physician reimbursement for medical imaging procedures
SPALTUDAQ CORPORATION via FABIANI & COMPANY
2009 · second_quarter · Q2
RDT&E Defense Appropriations 2010 Budget
RDT&E Defense Appropriations 2010 Budget
RDT&E Defense Appropriations 2010 Budget
OTONOMY CORPORATION via FABIANI & COMPANY
2009 · second_quarter · Q2
FY10 National Defense Authorization Act FY10 Defense Appropriations Bill
FY10 National Defense Authorization Act FY10 Defense Appropriations Bill
Filing targets: Army, Dept of (Other), HOUSE OF REPRESENTATIVES, Navy, Dept of, SENATE
VAXINNATE via FABIANI & COMPANY
2009 · first_quarter · 1T
Department of Defense Appropriations Act of 2009, provisions relating to funding for novel flu vaccine development
Department of Defense Appropriations Act of 2009, provisions relating to funding for novel flu vaccine development
Department of Defense Appropriations Act of 2009, provisions relating to Army funding for medical research
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TETRAPHASE PHARMACEUTICALS via FABIANI & COMPANY
2009 · second_quarter · Q2
Tetracycline / antibiotic use for bio-defense
Tetracycline / antibiotic use for bio-defense
Tetracycline / antibiotic use for bio-defense
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIMERADX via FABIANI & COMPANY
2009 · second_quarter · Q2
Governmnet funding and contracts related to multiplexing diagnostic device.
Governmnet funding and contracts related to multiplexing diagnostic device.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRAINCELLS INC via FABIANI & COMPANY
2009 · second_quarter · Q2
Defense Appropriations RDT&E
Defense Appropriations RDT&E
Defense Appropriations RDT&E
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institute of Mental Health (NIMH), Natl Institutes of Health (NIH), SENATE
VISION ROBOTICS via FABIANI & COMPANY
2009 · second_quarter · Q2
Department of Defense Appropriations Act of 2010, provisions relating to research and development of military robotics
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
PLANET BIOTECHNOLOGY INC via FABIANI & COMPANY
2009 · second_quarter · Q2
Department of Defense Appropriations Act of 2010, provisions relating to Department of Defense medical research (RDT&E)
Department of Defense Appropriations Act of 2010, provisions relating to Department of Defense medical research (RDT&E)
Department of Defense Appropriations Act of 2010, funding for biodefense product research
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
OCERA THERAPEUTICS INC. via FABIANI & COMPANY
2009 · second_quarter · Q2
Funding for biopharmaceutical product development to address nuclear warfare threats.
Fiscal Year 2010 Defense Appropriations Act. Funding for biopharmaceutical product trials for treatment to address long term health impact of substance abuse in military populations.
Funding for biopharmaceutical product development with the Department of Defense to treat long term health impact of chronic substance abuse.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
NANOTHERAPEUTICS INC via FABIANI & COMPANY
2009 · second_quarter · Q2
Department of Defense Appropriations Act of 2010, provisions relating to Army medical research
Research partnerships on treatments to address opiate addiction
Department of Defense Appropriations Act of 2010, provisions relating to Army medical research
MEDRAD, INC via FABIANI & COMPANY
2009 · second_quarter · Q2
Patent Reform Act, provisions relating to apportionment of damages
HR 6331 Medicare Bill- Issues pertaining to physician reimbursement for medical imaging procedures
Department of Commerce, Justice, Science & Related Agencies Appropriations Act of 2009, provisions relating to NASA funding and research; Department of Energy and Water and Related Agencies Appropriations Act of 2010, for medical imaging research
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, Natl Aeronautics & Space Administration (NASA), SENATE
ALNYLAM PHARMACEUTICALS via FABIANI & COMPANY
2009 · second_quarter · Q2
S.515. Patent Reform Act Provisions relating to apportionment of damages
S.515 Patent Reform Act Provisions relating to the apportionment of damages
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
3-V BIOSCIENCES, INC. via FABIANI & COMPANY
2009 · second_quarter · Q2
Pursuing government funding to support therapeutic platform development for infectious diseases
Pursuing government funding to support therapeutic platform development for infectious diseases
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRF COALITION via FABIANI & COMPANY
2009 · second_quarter · 2T
Abuse deterrent formulations of pharmaceutical products
Abuse deterrent formulations of pharmaceutical products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CLINICAL DATA INC via FABIANI & COMPANY
2009 · second_quarter · Q2
S.976 Genomics and Personalized Medicine Act of 2007, Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations
S.976 Genomics and Personalized Medicine Act of 2007, Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CEMPRA PHARMACEUTICALS INC. via FABIANI & COMPANY
2009 · second_quarter · Q2
Appropriation for antibiotic development
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TETRAPHASE PHARMACEUTICALS via FABIANI & COMPANY
2009 · second_quarter · RR
Tetracycline / antibiotic use for bio-defense
Tetracycline / antibiotic use for bio-defense
Tetracycline / antibiotic use for bio-defense
CEMPRA PHARMACEUTICALS INC. via FABIANI & COMPANY
2009 · first_quarter · Q1
Appropriation for antibiotic development
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDRAD, INC via FABIANI & COMPANY
2009 · first_quarter · Q1
HR 6331 Medicare Bill- Issues pertaining to physician reimbursement for medical imaging procedures
Patent Reform Act, provisions relating to apportionment of damages
Department of Commerce, Justice, Science & Related Agencies Appropriations Act of 2009, provisions relating to NASA funding and research; Department of Energy and Water and Related Agencies Appropriations Act of 2010, for medical imaging research
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, Natl Aeronautics & Space Administration (NASA), SENATE
OTONOMY CORPORATION via FABIANI & COMPANY
2009 · first_quarter · Q1
FY10 National Defense Authorization Act FY10 Defense Appropriations Bill
FY10 National Defense Authorization Act FY10 Defense Appropriations Bill
Filing targets: Army, Dept of (Other), HOUSE OF REPRESENTATIVES, SENATE
VISION ROBOTICS via FABIANI & COMPANY
2009 · first_quarter · Q1
Department of Defense Appropriations Act of 2010, provisions relating to research and development of military robotics
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
VAXINNATE via FABIANI & COMPANY
2009 · first_quarter · Q1
Department of Defense Appropriations Act of 2009, provisions relating to funding for novel flu vaccine development
Department of Defense Appropriations Act of 2009, provisions relating to Army funding for medical research
Department of Defense Appropriations Act of 2009, provisions relating to funding for novel flu vaccine development
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PLANET BIOTECHNOLOGY INC via FABIANI & COMPANY
2009 · first_quarter · Q1
Department of Defense Appropriations Act of 2010, provisions relating to Department of Defense medical research (RDT&E)
Department of Defense Appropriations Act of 2010, funding for biodefense product research
Department of Defense Appropriations Act of 2010, provisions relating to Department of Defense medical research (RDT&E)
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
OCERA THERAPEUTICS INC. via FABIANI & COMPANY
2009 · first_quarter · Q1
Fiscal Year 2010 Defense Appropriations Act. Funding for biopharmaceutical product trials for treatment to address long term health impact of substance abuse in military populations.
Funding for biopharmaceutical product development with the Department of Defense to treat long term health impact of chronic substance abuse.
Funding for biopharmaceutical product development to address nuclear warfare threats.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
NANOTHERAPEUTICS INC via FABIANI & COMPANY
2009 · first_quarter · Q1
Department of Defense Appropriations Act of 2010, provisions relating to Army medical research
Department of Defense Appropriations Act of 2010, provisions relating to Army medical research
Research partnerships on treatments to address opiate addiction
MEDRAD, INC via FABIANI & COMPANY
2009 · first_quarter · Q1
Department of Commerce, Justice, Science & Related Agencies Appropriations Act of 2009, provisions relating to NASA funding and research
Patent Reform Act, provisions relating to apportionment of damages
HR 6331 Medicare Bill- Issues pertaining to physician reimbursement for medical imaging procedures
Filing targets: HOUSE OF REPRESENTATIVES, Natl Aeronautics & Space Administration (NASA), SENATE
ALNYLAM PHARMACEUTICALS via FABIANI & COMPANY
2009 · first_quarter · Q1
S.515. Patent Reform Act Provisions relating to apportionment of damages
S.515 Patent Reform Act Provisions relating to the apportionment of damages
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
3-V BIOSCIENCES, INC. via FABIANI & COMPANY
2009 · first_quarter · Q1
Pursuing government funding to support therapeutic platform development for infectious diseases
Pursuing government funding to support therapeutic platform development for infectious diseases
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SPALTUDAQ CORPORATION via FABIANI & COMPANY
2009 · first_quarter · Q1
RDT&E Defense Appropriations 2010 Budget
RDT&E Defense Appropriations 2010 Budget
RDT&E Defense Appropriations 2010 Budget
PRIMERADX via FABIANI & COMPANY
2009 · first_quarter · Q1
Governmnet funding and contracts related to multiplexing diagnostic device.
Governmnet funding and contracts related to multiplexing diagnostic device.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRAINCELLS INC via FABIANI & COMPANY
2009 · first_quarter · Q1
Defense Appropriations RDT&E
Defense Appropriations RDT&E
Defense Appropriations RDT&E
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institute of Mental Health (NIMH), Natl Institutes of Health (NIH), SENATE
TRF COALITION via FABIANI & COMPANY
2009 · first_quarter · Q1
Abuse deterrent formulations of pharmaceutical products
Abuse deterrent formulations of pharmaceutical products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LUNDBECK RESEARCH USA, INC. via FABIANI & COMPANY
2009 · first_quarter · Q1
Health Reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CLINICAL DATA INC via FABIANI & COMPANY
2009 · first_quarter · Q1
S.976 Genomics and Personalized Medicine Act of 2007, Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations
S.976 Genomics and Personalized Medicine Act of 2007, Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
3-V BIOSCIENCES, INC. via FABIANI & COMPANY
2009 · first_quarter · RA
Pursuing government funding to support therapeutic platform development for infectious diseases
Pursuing government funding to support therapeutic platform development for infectious diseases
3-V BIOSCIENCES, INC. via FABIANI & COMPANY
2009 · first_quarter · RR
Pursuing government funding to support therapeutic platform development for infectious diseases
Pursuing government funding to support therapeutic platform development for infectious diseases
CEMPRA PHARMACEUTICALS INC. via FABIANI & COMPANY
2009 · first_quarter · RA
Appropriation for antibiotic development
LUNDBECK RESEARCH USA, INC. via FABIANI & COMPANY
2009 · first_quarter · RR
Health Reform
OTONOMY CORPORATION via FABIANI & COMPANY
2009 · first_quarter · RR
FY10 National Defense Authorization Act FY10 Defense Appropriations Bill
FY10 National Defense Authorization Act FY10 Defense Appropriations Bill
PLANET BIOTECHNOLOGY INC via FABIANI & COMPANY
2008 · fourth_quarter · Q4
Department of Defense Appropriations Act of 2009, provisions relating to DARPA medical research (RDT&E)
Department of Defense Appropriations Act of 2009, provisions relating to DARPA medical research (RDT&E)
Department of Defense Appropriations Act of 2009, funding for biodefense product research
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPALTUDAQ CORPORATION via FABIANI & COMPANY
2008 · fourth_quarter · Q4
DTRA BAA 2007 RDT&E Defense Appropriations 2009 Budget
DTRA BAA 2007 RDT&E Defense Appropriations 2009 Budget
DTRA BAA 2007 RDT&E Defense Appropriations 2009 Budget
BRAINCELLS INC via FABIANI & COMPANY
2008 · fourth_quarter · Q4
CDMRP - BAA 2007 Defense Appropriations RDT&E
CDMRP - BAA 2007 Defense Appropriations RDT&E
CDMRP - BAA 2007 Defense Appropriations RDT&E
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institute of Mental Health (NIMH), Natl Institutes of Health (NIH), SENATE
PLANET BIOTECHNOLOGY INC via FABIANI & COMPANY
2008 · fourth_quarter · Q4
Department of Defense Appropriations Act of 2009, provisions relating to DARPA medical research (RDT&E)
Department of Defense Appropriations Act of 2009, provisions relating to DARPA medical research (RDT&E)
Department of Defense Appropriations Act of 2009, funding for biodefense product research
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VISION ROBOTICS via FABIANI & COMPANY
2008 · fourth_quarter · Q4
Department of Defense Appropriations Act of 2009, provisions relating to research and development of military robotics
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
VAXINNATE via FABIANI & COMPANY
2008 · fourth_quarter · Q4
Department of Defense Appropriations Act of 2009, provisions relating to Army funding for medical research
Department of Defense Appropriations Act of 2009, provisions relating to funding for novel flu vaccine development
Department of Defense Appropriations Act of 2009, provisions relating to funding for novel flu vaccine development
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PRIMERADX via FABIANI & COMPANY
2008 · fourth_quarter · Q4
Governmnet funding and contracts related to multiplexing diagnostic device.
Governmnet funding and contracts related to multiplexing diagnostic device.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OCERA THERAPEUTICS INC. via FABIANI & COMPANY
2008 · fourth_quarter · Q4
Funding for biopharmaceutical product development with DOD to address nuclear warfare threats and treat long term health impact of chronic substance abuse.
Funding for biopharmaceutical product development with DOD to address nuclear warfare threats and treat long term health impact of chronic substance abuse.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDRAD, INC via FABIANI & COMPANY
2008 · fourth_quarter · Q4
Patent Reform Act, provisions relating to apportionment of damages
HR 6331 Medicare Bill- Issues pertaining to physician reimbursement for medical imaging procedures
Department of Commerce, Justice, Science & Related Agencies Appropriations Act of 2009, provisions relating to NASA funding and research
Filing targets: HOUSE OF REPRESENTATIVES, Natl Aeronautics & Space Administration (NASA), SENATE
ALNYLAM PHARMACEUTICALS via FABIANI & COMPANY
2008 · fourth_quarter · Q4
S.1145. Patent Reform Act Provisions relating to apportionment of damages
S.1145 Patent Reform Act Provisions relating to the apportionment of damages
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NANOTHERAPEUTICS INC via FABIANI & COMPANY
2008 · fourth_quarter · Q4
Department of Defense Appropriations Act of 2009, provisions relating to Army medical research
Department of Defense Appropriations Act of 2009, provisions relating to Army medical research
Department of Defense Appropriations Act of 2009, provisions relating to Army medical research
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
TRF COALITION via FABIANI & COMPANY
2008 · fourth_quarter · Q4
Abuse deterrent formulations of pharmaceutical products
Abuse deterrent formulations of pharmaceutical products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICIS PHARMACEUTICAL CORPORATION via FABIANI & COMPANY
2008 · fourth_quarter · 4T
Incentives for antibiotic innovation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CLINICAL DATA INC via FABIANI & COMPANY
2008 · fourth_quarter · Q4
S.976 Genomics and Personalized Medicine Act of 2007, Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations
S.976 Genomics and Personalized Medicine Act of 2007, Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CEMPRA PHARMACEUTICALS INC. via FABIANI & COMPANY
2008 · fourth_quarter · 4T
Incentives for antibiotic innovation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRF COALITION via FABIANI & COMPANY
2008 · fourth_quarter · RR
Abuse deterrent formulations of pharmaceutical products
Abuse deterrent formulations of pharmaceutical products
OCERA THERAPEUTICS INC. via FABIANI & COMPANY
2008 · fourth_quarter · RR
Funding for biopharmaceutical product development with DOD to address nuclear warfare threats and treat long term health impact of chronic substance abuse.
Funding for biopharmaceutical product development with DOD to address nuclear warfare threats and treat long term health impact of chronic substance abuse.
SPALTUDAQ CORPORATION via FABIANI & COMPANY
2008 · third_quarter · Q3
DTRA BAA 2007 RDT&E Defense Appropriations 2009 Budget
DTRA BAA 2007 RDT&E Defense Appropriations 2009 Budget
DTRA BAA 2007 RDT&E Defense Appropriations 2009 Budget
BRAINCELLS INC via FABIANI & COMPANY
2008 · third_quarter · Q3
CDMRP - BAA 2007 Defense Appropriations RDT&E
CDMRP - BAA 2007 Defense Appropriations RDT&E
CDMRP - BAA 2007 Defense Appropriations RDT&E
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
AKESIS PHARMACEUTICALS INC via FABIANI & COMPANY
2008 · third_quarter · 3T
Defense appropriations RDT&E
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
MEDICIS PHARMACEUTICAL CORPORATION via FABIANI & COMPANY
2008 · third_quarter · Q3
Incentives for antibiotic innovation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CLINICAL DATA INC via FABIANI & COMPANY
2008 · third_quarter · Q3
S.976 Genomics and Personalized Medicine Act of 2007, Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations
S.976 Genomics and Personalized Medicine Act of 2007, Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CEMPRA PHARMACEUTICALS INC. via FABIANI & COMPANY
2008 · third_quarter · Q3
Incentives for antibiotic innovation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VISION ROBOTICS via FABIANI & COMPANY
2008 · third_quarter · Q3
Department of Defense Appropriations Act of 2009, provisions relating to research and development of military robotics
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
VAXINNATE via FABIANI & COMPANY
2008 · third_quarter · Q3
Department of Defense Appropriations Act of 2009, provisions relating to Army funding for medical research
Department of Defense Appropriations Act of 2009, provisions relating to funding for novel flu vaccine development
Department of Defense Appropriations Act of 2009, provisions relating to funding for novel flu vaccine development
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PLANET BIOTECHNOLOGY INC via FABIANI & COMPANY
2008 · third_quarter · Q3
Department of Defense Appropriations Act of 2009, provisions relating to DARPA medical research (RDT&E)
Department of Defense Appropriations Act of 2009, provisions relating to DARPA medical research (RDT&E)
Department of Defense Appropriations Act of 2009, funding for biodefense product research
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NANOTHERAPEUTICS INC via FABIANI & COMPANY
2008 · third_quarter · Q3
Department of Defense Appropriations Act of 2009, provisions relating to Army medical research
Department of Defense Appropriations Act of 2009, provisions relating to Army medical research
Department of Defense Appropriations Act of 2009, provisions relating to Army medical research
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
MEDRAD, INC via FABIANI & COMPANY
2008 · third_quarter · Q3
Patent Reform Act, provisions relating to apportionment of damages
Department of Commerce, Justice, Science & Related Agencies Appropriations Act of 2009, provisions relating to NASA funding and research
HR 6331 Medicare Bill- Issues pertaining to physician reimbursement for medical imaging procedures
Filing targets: HOUSE OF REPRESENTATIVES, Natl Aeronautics & Space Administration (NASA), SENATE
S 515 Patent Reform Act, provisions relating to apportionment of damages
Filing targets: Commerce, Dept of (DOC), Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
Department of Commerce, Justice, Science & Related Agencies Appropriations Act of 2009, provisions relating to NASA funding and research; Department of Energy and Water and Related Agencies Appropriations Act of 2010, for medical imaging research
Filing targets: Commerce, Dept of (DOC), Energy, Dept of, HOUSE OF REPRESENTATIVES, Natl Aeronautics & Space Administration (NASA), SENATE
RDT&E Defense Appropriations 2010 Budget
RDT&E Defense Appropriations 2010 Budget
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Department of Defense Appropriations Act of 2010, provisions relating to Army medical research
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
Department of Defense Appropriations Act of 2010, provisions relating to Army medical research
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
RDT&E Defense Appropriations 2010 Budget
RDT&E Defense Appropriations 2010 Budget
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
DTRA BAA 2007 RDT&E Defense Appropriations 2009 Budget
DTRA BAA 2007 RDT&E Defense Appropriations 2009 Budget
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
DTRA BAA 2007 RDT&E Defense Appropriations 2009 Budget
DTRA BAA 2007 RDT&E Defense Appropriations 2009 Budget
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE